Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00368108 · ClinicalTrials.gov registry record · Phase 3
Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
A Phase 3 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 3
- Development phase
- 752
- Enrollment target
NCT00368108 is a Phase 3 study that has completed, run by Eisai. The registered enrollment target is 752 participants.
The verdict
NCT00368108, a Phase 3 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 752 participants
- Enrollment target
Study Summary
This is a multi-center, randomized, double-blind, placebo-controlled, parallel-group study of E2007 in levodopa treated Parkinson's disease patients with motor fluctuations.
Interventions
- DRUG placebo comparator
- DRUG 2 mg perampanel
- DRUG 4 mg perampanel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 752 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00368108
The ClinicalTrials.gov registry entry for NCT00368108 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 752 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo comparator is the first listed.
NCT00368108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00368108 about?
NCT00368108 is a clinical study titled "Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations". This is a multi-center, randomized, double-blind, placebo-controlled, parallel-group study of E2007 in levodopa treated Parkinson's disease patients with motor fluctuations.
What is the current status of trial NCT00368108?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 752 participants. The study started on 2006-08. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00368108?
The interventions under investigation include: placebo comparator (DRUG), 2 mg perampanel (DRUG), 4 mg perampanel (DRUG).
Who is sponsoring clinical trial NCT00368108?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.